45 CFR § 180 compliance
F · 55
This hospital published little of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
○Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
16,676
Insurances with rates
5
CPT / HCPCS codes
13,030
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J2351 | ocrelizumab-hyaluronidase-ocsq 920-23000 mg-unit/23 mL Solution 23 mL Vial | $175,458 | $96,502 | — | — | 11 |
| J9228 | ipilimumab 200 MG/40ML Solution 40 mL Vial | $145,601 | $80,080 | — | — | 11 |
| J9269 | tagraxofusp-erzs 1000 MCG/ML Solution 1 mL Vial | $138,417 | $76,130 | — | — | 11 |
| J2507 | Pegloticase 8 MG/ML Solution 1 mL Vial | $127,605 | $70,183 | — | — | 11 |
| J0202 | alemtuzumab 12 MG/1.2ML Solution 1.2 mL Vial | $125,171 | $68,844 | — | — | 11 |
| J1747 | spesolimab-sbzo 450 MG/7.5ML Solution 7.5 mL Vial | $118,599 | $65,229 | — | — | 11 |
| J9359 | loncastuximab tesirine-lpyl 10 mg/2 mL Recon Soln 1 Each Vial | $113,857 | $62,621 | — | — | 11 |
| J9281 | mitoMYcin 80 (2 x 40) MG Recon Soln 1 Each Box | $100,383 | $55,211 | — | — | 11 |
| J9229 | inotuzumab ozogamicin 0.25 mg/ml Recon Soln 1 Each Vial | $93,938 | $51,666 | — | — | 11 |
| J2350 | ocrelizumab 300 MG/10ML Solution 10 mL Vial | $87,734 | $48,254 | — | — | 11 |
| J0638 | canakinumab 150 mg/mL Solution 1 mL Vial | $85,952 | $47,274 | — | — | 11 |
| J9274 | Tebentafusp-tebn 100 MCG/0.5ML Solution 0.5 mL Vial | $83,983 | $46,191 | — | — | 11 |
| J9309 | polatuzumab vedotin-piiq 20 mg/mL Recon Soln 1 Each Vial | $76,322 | $41,977 | — | — | 22 |
| J3241 | teprotumumab-trbw 500 MG Recon Soln 1 Each Vial | $74,432 | $40,938 | — | — | 11 |
| J9334 | efgartigimod alfa-hyaluronidase-qvfc 1008-11200 mg-UT/5.6 mL Solution 5.6 mL Vial | $68,386 | $37,612 | — | — | 11 |
| J9026 | tarlatamab-dlle 10 MG Recon Soln 1 Each Vial | $63,760 | $35,068 | — | — | 11 |
| J9298 | nivolumab-relatlimab-rmbw 240-80 mg/20mL Solution 20 mL Vial | $62,005 | $34,103 | — | — | 11 |
| J1628 | guselkumab 200 MG/20ML Solution 20 mL Vial | $61,917 | $34,055 | — | — | 11 |
| J9381 | teplizumab-mzwv 2 MG/2ML Solution 2 mL Vial | $59,100 | $32,505 | — | — | 11 |
| J9043 | cabazitaxel Solution 1.5 mL Vial | $58,886 | $32,387 | — | — | 11 |
| J1323 | elranatamab-bcmm 76 mg/1.9 mL Solution 1.9 mL Vial | $56,444 | $31,044 | — | — | 11 |
| 37227 | HC REVASC, ENDVASC, FEM, POPLIT ART, W STENT & ATHRECT | $53,268 | $29,297 | — | — | 9 |
| J9271 | pembrolizumab 200 mg 200 mg Solution 58 mL Bag | $51,853 | $28,519 | — | — | 22 |
| J0896 | luspatercept-aamt 50 mg/mL Recon Soln 1 Each Vial | $51,424 | $28,283 | — | — | 22 |
| J9042 | brentuximab 5 mg/mL Recon Soln 1 Each Vial | $50,035 | $27,519 | — | — | 22 |
| J9272 | dostarlimab-gxly 500 MG/10ML Solution 10 mL Vial | $48,372 | $26,605 | — | — | 11 |
| 37231 | HC REVASC, ENDVASC, TIB, PERON ART, INIT VES, W STENT & ATHRECT | $46,364 | $25,500 | — | — | 9 |
| J9022 | atezolizumab 1200 MG/20ML Solution 20 mL Vial | $46,147 | $25,381 | — | — | 11 |
| J9024 | atezolizumab-hyaluronidase-tqjs 1875-30,000 mg-unit/15 mL Solution 15 mL Vial | $46,147 | $25,381 | — | — | 11 |
| J3055 | talquetamab-tgvs 40 MG/ML Solution 1 mL Vial | $45,692 | $25,131 | — | — | 33 |
| C9797 | HC VASC EMBO/OCCLUS W/ USE OF PRESS GEN CATH, TUM, ORG ISCHEMIA/INFARCTION | $45,619 | $25,090 | — | — | 9 |
| J9119 | cemiplimab-rwlc 350 MG/7ML Solution 7 mL Vial | $44,807 | $24,644 | — | — | 11 |
| C9773 | HC REVASC, ENDOVASC, OPEN/PERC, TIB/PERON ART, W/ IVL & TRANSLUM STENC | $44,606 | $24,533 | — | — | 9 |
| J9153 | DAUNOrubicin-cytarabine liposomal 44-100 MG Recon Susp 1 Each Vial | $44,162 | $24,289 | — | — | 11 |
| J2327 | risankizumab-rzaa 600 MG/10ML Solution 10 mL Vial | $44,094 | $24,252 | — | — | 11 |
| 36836 | HC PERC ARTVEN FIST CREAT, UPR EXTREM, SGL ACC PERIPH ART&VEIN, IMG GUID | $44,079 | $24,243 | — | — | 9 |
| J9144 | daratumumab-hyaluronidase-fihj 1800-30000 mg-UT/15 mL Solution 15 mL Vial | $43,360 | $23,848 | — | — | 11 |
| 36906 | HC PERC TRANSLUM MECH THROMBECT/INFUS, DIALYS CIRCUIT, PERIPH STENT/PTA | $42,138 | $23,176 | — | — | 9 |
| J0870 | imetelstat sodium 188 MG Recon Soln 1 Each Vial | $41,755 | $22,965 | — | — | 11 |
| J7313 | fluocinolone acetonide 0.19 MG Implant 1 Each Box | $38,553 | $21,204 | — | — | 11 |
| J3263 | toripalimab-tpzi 240 mg/6 mL Solution 6 mL Vial | $38,118 | $20,965 | — | — | 11 |
| J9316 | pertuzumab/trastuzumab/hyaluronidase-zzxf 60-60-2000 MG-MG-U/ML Solution 10 mL Vial | $38,052 | $20,929 | — | — | 11 |
| J9299 | nivolumab Solution 124 mL Flex Cont | $37,387 | $20,563 | — | — | 11 |
| 37225 | HC REVASC, ENDVASC, FEM, POPLIT ART, W ATHRECT | $37,096 | $20,403 | — | — | 9 |
| C9047 | caplacizumab-yhdp 11 MG Kit 1 Each Box | $36,440 | $20,042 | — | — | 8 |
| J2323 | natalizumab 300 MG/15ML Conc 15 mL Vial | $36,295 | $19,962 | — | — | 11 |
| C9772 | HC REVASC, ENDOVASC, OPEN/PERC, TIBIAL/PERONEAL ART, W INTRVASC LITHOTRIPSY | $35,409 | $19,475 | — | — | 9 |
| J9301 | obinutuzumab 1000 MG/40ML Solution 40 mL Vial | $35,327 | $19,430 | — | — | 11 |
| J3101 | tenecteplase 50 mg/10 mL Kit 1 Each Box | $35,273 | $19,400 | — | — | 11 |
| J1930 | lanreotide acetate 90 MG/0.3ML Solution 0.3 mL Syringe | $34,469 | $18,958 | — | — | 11 |
Showing top 50 of 16,676 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.